Y-Intercept »

Karyopharm Therapeutics shares owned by Y-Intercept

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Y-Intercept

Quarter filed Position value Share count Share price at filing
2026-06-30 $101k 10k 9.77

More positions owned by Y-Intercept

Amazon (AMZN)
Apple (AAPL)
Boston Scientific Corporation (BSX)
Microsoft Corporation (MSFT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
salesforce (CRM)
Cme (CME)
Cognizant Technology Solutio Cl A (CTSH)
Intuit (INTU)
Qualcomm (QCOM)
CBOE Holdings (CBOE)
NVIDIA Corporation (NVDA)
Accenture Plc Ireland Shs Class A (ACN)
Monolithic Power Systems (MPWR)
JPMorgan Chase & Co. (JPM)

View all positions for Y-Intercept

Top funds holding Karyopharm Therapeutics

RA Capital Management
Adage Capital Partners GP
Acorn Capital Advisors
Goldman Sachs Group
BlackRock
Vanguard Capital Management
Catalio Capital Management
Avidity Partners Management
Two Sigma Investments
Kalehua Capital Management
NEA Management Company
Susquehanna International
Geode Capital Management
Ghisallo Capital Management
Soleus Capital Management

View all funds holding Karyopharm Therapeutics